Adenosine as a modulator of brain activity

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Adenosine is an endogenous neuromodulator vital for brain function.
• Dysregulation of the adenosine system is implicated in neurological and psychiatric conditions like epilepsy and neurodegenerative diseases.
• The adenosine system is a key therapeutic target for neurological disorders.

Purpose of the Study:

• To review upstream and downstream targets of adenosinergic neurotransmission.
• To provide the neurochemical rationale for developing adenosine receptor modulators and adenosine kinase inhibitors.
• To highlight the potential of adenosine-based therapies for neurological diseases.

Main Methods:

• Literature review of adenosinergic neurotransmission.
• Analysis of upstream regulators (adenosine kinase) and downstream targets (adenosine receptors).
• Examination of preclinical and clinical studies on adenosine-regulating agents.

Main Results:

• Adenosine integrates and fine-tunes glutamatergic and dopaminergic neurotransmission.
• Adenosine receptor modulating drugs and adenosine kinase inhibitors are viable therapeutic approaches.
• Adenosine-regulating agents demonstrate broad potential for modifying neurological functions.

Conclusions:

• Adenosine-based therapies are rapidly advancing in preclinical and clinical research.
• Targeting the adenosine system offers a promising avenue for treating a spectrum of neurological diseases.
• Understanding adenosine's role in neurotransmission is key to developing effective neurological treatments.